Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma GroupUlrich Keilholz, Alexander M.M. Eggermont, Poulam Patel et al.|Journal of Clinical Oncology|2005Cited by 166
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma GroupAndrew Bottomley, Alexander M.M. Eggermont, Corneel Coens et al.|Journal of Clinical Oncology|2009Cited by 116